News

Georgia Tech engineers have created a pill that could effectively deliver insulin and other injectable drugs, making ...
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the ...
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply.
Levemir gained Food and Drug Administration approval as a treatment for diabetes in 2005. Newer, longer-acting insulins have since hit the market and even more insulin medications are being developed.
$35 price cap Sanofi established a $35 monthly cap on out-of-pocket costs for Lantus, its most widely prescribed insulin in the US, for all patients with commercial insurance starting January 1.
GoodRx announced on Oct. 19 that it is partnering with Paris-based pharma giant Sanofi to provide a 30-day supply of Sanofi’s widely prescribed insulin drug Lantus at a discounted cost of $35.
All Americans with a valid prescription, regardless of their insurance status, can use GoodRx at more than 70,000 retail pharmacies to access a 30-day supply of Lantus for $35.
Sanofi also later agreed to lower Lantus’ list price by 78% and limit out-of-pocket costs for the drug to $35 for buyers with commercial insurance. Both of Sanofi’s initiatives take effect in ...
Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...
The unbranded insulin glargine has a wholesale acquisition cost (WAC) of $99. However, Sanofi, the maker of Lantus, will reduce the price 78% starting January 2024.
Lantus 100iu - 3 ml Injection (Insulin Glargine) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is manufactured by Sanofi ...